期刊文献+

2例同时性双侧肾癌的诊治并文献复习 被引量:3

下载PDF
导出
摘要 目的报道2例同时性双侧肾癌的诊治经过,并结合相关文献对同时性双侧肾癌的诊断、鉴别诊断及其治疗进行探讨。方法 2例肾癌患者经B超、增强CT及MRI检查高度怀疑双肾恶性肿瘤,均行分期手术治疗,分别为一侧肾肿瘤剜除术及对侧根治性切除术和双侧肾部分切除术,其中1例手术间期和术后给予生物靶向药物索拉非尼治疗。结果 2例患者共行4次手术,均成功。术中所见病灶数目与术前影像学检查结果一致,均未发现腹腔转移以及远处转移,无肾静脉及下腔静脉栓子形成。病理证实1例为右肾多房性囊性肾细胞癌、左肾多发性透明细胞癌,另1例为右肾透明细胞癌、左肾多房性囊性肾细胞癌。术后均顺利恢复,无外科并发症。术后分别随访20个月和6个月,无局部复发、转移及肾功能不全。结论同时性双侧肾癌的诊断主要依赖腹部B超、增强CT及MRI等影像学检查,治疗上应根据肿瘤的特性和患者的全身状况综合评估选择手术方式,在兼顾肾肿瘤治疗的基础上,力求最大限度地保留肾单位。生物靶向药物结合手术治疗有望改善同时性双侧肾癌患者的预后。
出处 《山东医药》 CAS 2013年第20期64-66,F0003,共4页 Shandong Medical Journal
  • 相关文献

参考文献12

  • 1邓国贤,胡自力.双侧肾癌的诊治进展[J].重庆医学,2011,40(23):2387-2389. 被引量:5
  • 2Boorjian SA, Crispen PL, Lohse CM, et al. The impact of tempo- ral presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses[ J ]. Eur U r o l, 2008,54 (4) : 855 -863. 被引量:1
  • 3Klatte T, Wunderlieh H, Patard JJ, et al. Clinieopathologieal fea- tures and prognosis of synchronous bilateral renal cell carcinoma: an international multieentre experience [ J ]. BJU Int, 2007,100 (1) :21-25. 被引量:1
  • 4Neumann HP, Wiestler OD. Von Hippel-Lindan disease: a syn- drome providing insights into growth control and tumorigenesis[J]. Nephrol Dial Transplant, 1994,9(12) :1832-1833. 被引量:1
  • 5Petersson FM, Michal T, Vanecek, et al. Bilateral renal tumors; conventional clear cell carcinoma and contralateral t ( 6 ; 11 )/t ( X ; 17)-like tumor Histomorphologic, immunohistochemical, ultra- structural and molecular genetic studies including the report of a novel mutation in the VHL gene[ J ]. Ann Diagn Pathol, 2011,15 (5) :362-369. 被引量:1
  • 6Kandt RS, Haines JL, Smith M, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease[J]. Nat Genet, 1992,2(1) :37-41. 被引量:1
  • 7Dimarco DS, Lohse CM, Zincke H, et al. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma ac- cording to histologic subtype compared with patients with solitary tumors after radical nephrectomy [ J ]. Urology, 2004,64 ( 3 ) : 462-467. 被引量:1
  • 8Crispen PL, Lohse CM, Blute ML. Muhifocal renal cell carcino- ma : clinicopathologic features and outcomes for tumors < / = 4 cm [J]. Adv Urol, 2008:518091. 被引量:1
  • 9Motzer R J, Hutson TE, Tomczak P, et al. Sunitinib versus interfer- on alfa in metastatic renal-cell carcinoma [ J ]. N Engl J Med, 2007,356 (2) : 115-124. 被引量:1
  • 10Escudier B. Sorafenib for the management of advanced renal cell carcinoma[ J ]. Expert Rev Antieancer Ther, 2011, 11 ( 6 ) : 825 -836. 被引量:1

二级参考文献31

共引文献4

同被引文献30

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部